If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Weichung Shih is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Clinical Trials Mathematics
Prostatic Neoplasms Medicine & Life Sciences
Sample Size Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Carcinogenesis Medicine & Life Sciences
Celecoxib Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Drop out Mathematics

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1985 2019

Phase I neoadjuvant study of intravesical recombinant fowlpox-GM-CSF (rF-GM-CSF) or fowlpox-TRICOM (rF-TRICOM) in patients with bladder carcinoma

Portal, D. E., Weiss, R. E., Wojtowicz, M., Mansour, A., Monken, C., Mehnert, J., Aisner, J., Kane, M., Nishioka, J., Aisner, S., Peters, S., Stein, M., Kim, I., Mayer, T. M., Shih, W., Gulley, J., Streicher, H., Singer, E. A. & Lattime, E., Jan 1 2019, In : Cancer gene therapy.

Research output: Contribution to journalArticle

Granulocyte-Macrophage Colony-Stimulating Factor
Urinary Bladder
Urinary Bladder Neoplasms
1 Citation (Scopus)

Tinagl1 Suppresses Triple-Negative Breast Cancer Progression and Metastasis by Simultaneously Inhibiting Integrin/FAK and EGFR Signaling

Shen, M., Jiang, Y. Z., Wei, Y., Ell, B., Sheng, X., Esposito, M., Kang, J., Hang, X., Zheng, H., Rowicki, M., Zhang, L., Shih, W., Celià-Terrassa, T., Liu, Y., Cristea, II., Shao, Z. M. & Kang, Y., Jan 14 2019, In : Cancer Cell. 35, 1, p. 64-80.e7

Research output: Contribution to journalArticle

Triple Negative Breast Neoplasms
Interstitial Nephritis
Focal Adhesion Protein-Tyrosine Kinases
Epidermal Growth Factor Receptor

Unbound bilirubin measurements by a novel probe in preterm infants

Hegyi, T., Kleinfeld, A., Huber, A., Weinberger, B., Memon, N., Shih, W., Carayannopoulos, M. & Oh, W., Aug 18 2019, In : Journal of Maternal-Fetal and Neonatal Medicine. 32, 16, p. 2721-2726 6 p.

Research output: Contribution to journalArticle

Premature Infants
Serum Albumin
3 Citations (Scopus)

A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanoma

Mehnert, J., Silk, A., Lee, J. H., Dudek, L., Jeong, B. S., Li, J., Schenkel, J. M., Sadimin, E., Kane, M., Lin, H., Shih, W., Zloza, A., Chen, S. & Goydos, J., Jul 1 2018, In : Pigment Cell and Melanoma Research. 31, 4, p. 534-540 7 p.

Research output: Contribution to journalArticle

16 Citations (Scopus)

Design and baseline characteristics of the eValuation of ERTugliflozin effIcacy and Safety CardioVascular outcomes trial (VERTIS-CV)

VERTIS-CV Investigators, Dec 1 2018, In : American heart journal. 206, p. 11-23 13 p.

Research output: Contribution to journalArticle

Type 2 Diabetes Mellitus
Sodium-Glucose Transporter 2
Cardiovascular Diseases